Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2011; 3(02): 080-083
DOI: 10.4103/0974-2727.86838
Original Article

Prevalence of bla CTX M Extended Spectrum Beta Lactamase Gene in Enterobacteriaceae from Critical Care Patients

R Indra Priyadharsini
Department of Microbiology, VMKV Medical College, Salem, Tamilnadu, India
,
A Kavitha
Department of Microbiology, VMKV Medical College, Salem, Tamilnadu, India
,
Reena Rajan
Department of Microbiology, VMKV Medical College, Salem, Tamilnadu, India
,
S Mathavi
Department of Microbiology, VMKV Medical College, Salem, Tamilnadu, India
,
K R Rajesh
Department of Microbiology, VMKV Medical College, Salem, Tamilnadu, India
› Author Affiliations Source of Support: Nil
› Further Information
Also available at
  PDF Download Permissions and Reprints

ABSTRACT

Context: Critical care units provide a favourable environment for the antimicrobial resistant organisms to disseminate. There is recent increase in number of extended spectrum beta lactamase (ESBL) producers because of the emergence of CTX M Beta lactamases produced by Enterobacteriaceae. They colonize the intestinal flora and spread with greater intensity in the community and hospital. Usage of Carbapenems becomes mandatory as the ESBL inhibitor combination antibiotics (Amoxicillin/Clavulanate) are not effective especially against CTX M ESBLs.

Aim: The aim of this study is to detect ESBL producing bla CTX M gene in Enterobacteriaceae from infections in Critical care patients and to stress on the intensity of the problem and to make interventions to curb the emergence and dissemination of CTX M ESBLs.

Materials and Methods: A total of 118 Enterobacteriaceae isolates from Critical care unit patients were recovered from a variety of clinical specimens. Antimicrobial susceptibility test was done and isolates with resistance or with reduced susceptibility to any of the third generation Cephalosporins were selected for the study. Phenotypic confirmation of ESBL production was done by Double Disc Synergy Test and confirmed by minimum inhibitory concentration. Multiplex polymerase chain reaction was performed to screen the four groups of CTX-M ESBLs.

Results: Among the 118 isolates of Enterobacteriaceae 54 isolates were positive for CTX-M group I ESBL which constitutes 45.7 %.

Conclusions: Early detection of CTX M producing Enterobacteriaceae by continuous surveillance and thereby reducing their spread and restricted use of third generation Cephalosporins (3GC) antibiotics could be the possible routes to prevent the emergence and spread of CTX M ESBL producing organisms.

Keywords

CTX M - Critical care - Enterobacteriaceae - Extended spectrum beta lactamase


Publication History

Article published online:
09 May 2020

© 2011.

Thieme Medical and Scientific Publi shers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Livermore DM, Hawkey PM. CTX M Changing The Face Of ESBLs in UK. J Antimicrob Chemother 2005;56:451-4.
  • 2 Mackie, McCartney. Chapter 20 Enterobacteriaceae. J.Gerald Collee. Practical Medical Microbiology. 14th ed. New Delhi: Elsevier; 2007. p. 362-3.
  • 3 Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 20th informational supplement: M100-S20U Journal Of Clinical Microbiology 2010;30:1-16
  • 4 Vercauteren E, Descheemaeker P, Ieven M, Sanders CG, Goossens H. Comparison of Screening methods for detection of extended spectrum lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella speciesin a Belgian Teaching Hospital. J Clin Microbiol 1997;35:2191-7.
  • 5 National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 5th ed. Wayne, PA, USA: NCCLS, Approved Standard; 2000. p. M7-A5.
  • 6 Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M lactamases produced by Escherichia coli and Klebsiella species J Clin Microbiol 2004;42:5715-21.
  • 7 Haley RW, Bregman DA. The role of understaffing and overcrowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit. J Infect Dis. 1982;145:875-85.
  • 8 McGowan JE. Antibiotic resistance in hospital bacteria: current patterns, modes for appearance or spread, and economic impact. Rev Med Microbiol 1991;2:161-9.
  • 9 Appelgren P, Hellstrom I, Weitzberg E, Soderlund V, Bindslev L, Ransjo U. Risk factors for nosocomial intensive care infection - a long-term prospective analysis. Acta Anaesthesiol Scand 2001;45:710-9.
  • 10 Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-21.
  • 11 Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al.The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639-44.
  • 12 Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ, et al. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. JAMA 1999;281:67-71.
  • 13 Archibald L, Phillips L, Monnet D, McGowan JE, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997;24:211-5.
  • 14 Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp from intensive care units in Europe. J Antimicrob Chemother 1996;38:409-24.
  • 15 Munday CJ, Whitehead GM, Todd NJ, Campbell M, Hawkey PM. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK. J Antimicrob Chemother 2004;54:628-33.
  • 16 Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004;42:4769-75.
  • 17 Baby Padmini S, Appala Raju B, Mani KR. Detection of Enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases from a tertiary care hospital in South India. Indian J Microbiol 2008;26:163-6.
  • 18 Lewis JS 2nd , Herrera M, Wickes B, Patterson JE, Jorgensen JH. First report of the emergence of CTX-M-type extended-spectrum ß-lactamases as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 2007;51:4015-21.
  • 19 Muzaheed, Doi Y, Adams-Haduch JM, Shivannavar CT, Paterson DL, Gaddad SM. Faecal carriage of CTX-M-15-producing Klebsiella pneumoniae in patients with acute gastroenteritis. Indian J Med Res 2009;129:599-602.
  • 20 Bonnet R, Growing Group of Extended-Spectrum ß-Lactamases: the CTX-M Enzymes. Antimicrob Agents Chemother 2004;48:1-14.
  • 21 Verma A, Desai N, Shannon K, Philpott-Howard J, Hill RL. Intra- and inter-generic plasmid-mediated spread of cephalosporin and aminoglycoside resistance amongst Klebsiella aerogenes K41 and other enterobacteria. Int J Antimicrob Agents 2001;17:123-9.